Cargando…
A Novel Neurotrophic Drug for Cognitive Enhancement and Alzheimer's Disease
Currently, the major drug discovery paradigm for neurodegenerative diseases is based upon high affinity ligands for single disease-specific targets. For Alzheimer's disease (AD), the focus is the amyloid beta peptide (Aß) that mediates familial Alzheimer's disease pathology. However, given...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237323/ https://www.ncbi.nlm.nih.gov/pubmed/22194796 http://dx.doi.org/10.1371/journal.pone.0027865 |